Pharmafile Logo

Wales’ New Treatments Fund

- PMLiVE

New ABPI partnership team should be NHS ‘bridge-head’ for industry

Partnership team will be lead by Kevin Blakemore, formerly of UCB and GSK

NHS reforms pass as draft risk register leaked

Queen grants Royal Assent to controversial Health Bill on same day document describing problems of reforms finds way to press

UK’s NHS reform bill on course to become law

Final attempt from Labour opposition to postpone the health reforms fails

- PMLiVE

Redefining value in healthcare communications

The changing healthcare environment offers communicators the opportunity to devise intelligent and creative new strategies

- PMLiVE

Pillars of success in market access

The key to true market access success begins with corporate ownership…

- PMLiVE

Proving value in uncertain times

Industry needs to be perceived as a contributor to healthcare solutions not just a cost

- PMLiVE

How to win through integrating market access

Embedding and integrating market access strategies company-wide is key

- PMLiVE

The role of systematic review in market access

Modern market access activities need to be evidence-based. But what does this really mean for new products being taken to market around the world? 

UK reaffirms NHS access to NICE-approved drugs

Health Secretary makes pledge on same day Future Forum recommendations on NHS reform accepted

Interview: Stephen Whitehead, ABPI

The CEO of the Association of the British Pharmaceutical Industry tells Tom Meek he is passionate about putting reputation and partnership at the heart of the UK industry

- PMLiVE

The formation of the NHS

Exploring the industry's most important dates, we recall July 1948: the formation of the NHS in the UK

- PMLiVE

Feeling the heat: The impact on Lansley of NHS reform

Will the pressure to deliver the government's £20bn savings goal break or make Andrew Lansley?

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links